PROGRAM
PRE-CONGRES COURSE PROGRAM

Important Key Opinion Leaders that confirmed their participation!

Stefan Agewall (Norway)

1 Stefan Agewall

Professor and senior consultant in cardiology at Oslo University Hospital in Norway
Editor-in-Chief of European Heart Journal-Cardiovascular Pharmacotherapy

My 3 favourites
Friday, October 28, 2022 – 12:15-12:30
Session: The Best of the Year in Cardiovascular Therapy (ECR, the official journal of ISCP and EJCVP, ESC family journal)
Repercusions of aging and frailty
Friday, October 28, 2022 – 14:00-14:10
Session: Cardiovascular pharmacotherapy in the elderly (Join WG-CVP)

Celso Amodeo (Brazil)

2 Celso Amodeo

Cardiologist and Nephrologist.
Collaborating physician in the Hypertensive Cardiopathy Sector of the Federal University of São Paulo

How to diagnose and treat resistant hypertension?
Thursday, October 27, 2022 – 16:00-16:10
Session: Pharmacotherapy for hypertension in the world
Treatment of anemia with and without renal disease
Saturday, October 29, 2022 – 11:20-11:30
Session: New drugs
Chairperson
Thursday, October 27, 2022 – 18:00-19:05
Session: How to manage Chronic Coronary Syndromes (II) – ESC guidelines and beyond 

Stefan D. Anker (Germany)

3 Stefan Anker

Professor of (Tissue) Homeostasis in Cardiology & Metabolism
Charité Campus Virchow-Klinikum, Berlin, Germany

HFpEF-Therapy: what can be considered established? What is in the pipeline?
Friday, October 28, 2022 – 09:20-09:30
Session: Drugs in heart failure (I) – ESC guidelines and beyond 

Sotiris Antoniou (UK)

4 Sotiris Antoniu

Professor
Honorary senior research associate at UCL School of Pharmacy
Head of Pharmacy at St Bartholomew’s Hospital

Polipharmacy
Friday, October 28, 2022 – 14:10-14:20
Session: Cardiovascular pharmacotherapy in the elderly (Join WG-CVP)
Chairperson
Friday, October 28, 2022 – 16:05-17:00
Session: Controversial therapies
Chairperson
Saturday, October 29, 2022 – 11:00-11:40
Session: New drugs

Pablo Avanzas (Spain)

5 Pablo Avanzas

Professor of Medicine in Oviedo University and Coordinator, Cardiovascular, Respiratory and Renal Systems Research Division at Health Research Institute of Asturias, ISPA, Oviedo, Spain

Management of CCS/obstructive CAD – Lessons from ISCHEMIA trial
Friday, October 28, 2022 – 16:05-16:15
Session: Controversial therapies
My 3 favourites
Friday, October 28, 2022 – 12:30-12:45
Session: The Best of the Year in Cardiovascular Therapy (ECR, the official journal of ISCP and EJCVP, ESC family journal)

Sang-Hong Baek (South Korea)

6 Sang Hong BAEK

Emeritus Professor
The Catholic University of Korea, College of Medicine, Seoul, Republic of Korea
President Elect, International Society of Cardiovascular Pharmacotherapy

Chairperson
Thursday, October 27, 2022 – 16:35-17:40
Session: How to manage Chronic Coronary Syndromes (I) – ESC guidelines and beyond
Always Betablockers post myocardial infarction?
Friday, October 28, 2022 – 16:15-16:25
Session: Controversial therapies
Presentation of ISCP 2023 congress
Saturday, October 29, 2022 – 11:55-12:05

Elisabeta Bădilă (Romania)

7 Elisabeta Bădilă

Professor  of Cardiology, “Carol Davila” University of Medicine and Pharmacy
Senior physician in Cardiology and Internal Medicine, Cardiology Dpt, Colentina Clinical Hospital

SGLT2i pros/cons
Saturday, October 29, 2022 – 10:00-10:10
Session: How to choose for management of DM in patients with CV disease

Șerban Bălănescu (Romania)

8 Serban_Balanescu

Professor of Cardiology and Internal Medicine, “Carol Davila”
University of Medicine and Pharmacy, Bucharest.

Digoxin No or Yes. When?
Friday, October 28, 2022 – 16:25-16:35
Session: Controversial therapies

Dennis Cokkinos (Greece)

9 Dennis V. Cokkinos

Clinical Professor Heart and Vessel  Dept
Biomedical Research Foundation, Academy of Athens

Drug prevention of Aortic Stenosis
Saturday, October 29, 2022 – 09:20-09:30
Session: New trends in prevention pharmacotherapy – Joint European Association of Professors Emeriti (EAPE)

Filippo Crea (Italy)

10 Filippo Crea

Professor of Cardiology, Director of the Department of Cardiovascular Sciences, Director of the Postgraduate School in Cardiology and Coordinator of the PhD program in Cellular and Molecular Cardiology at the Catholic University in Rome
Editor-in-Chief of the European Heart Journal

The meaning of OMT in the INOCA era
Thursday, October 27, 2022 – 16:45-16:55
Session: How to manage Chronic Coronary Syndromes (I) – ESC guidelines and beyond

G.-Andrei Dan (România)

11 Gheorghe Andrei Dan

Distinguished Professor of Cardiology and Internal Medicine
Carol Davila University of Medicine
Colentina University Hospital
Past president of International Society of Cardiovascular Pharmacotherapy

How to prevent and treat arrhythmias in cancer patients
Friday, October 28, 2022 – 11:30-11:40
Session: Drugs & cancer
Chairperson
Friday, October 28, 2022 – 12:15-12:45
Session: The Best of the Year in Cardiovascular Therapy (ECR, the official journal of ISCP and EJCVP, ESC family journal)
Chairperson
Friday, October 28, 2022 – 17:10-17:35
Session: Presentation of the best 3 abstracts (5 min/each + 5 min discussion + Awards to them)
Chairperson
Friday, October 28, 2022 – 17:35-18:25
Session: Neufeld Lecture
Quick sinopsis of 2022 congress
Saturday, October 29, 2022 – 11:40-11:55

Mario DiazNuila (Spain)

12 Mario Diaz Nuila

Doctor at Autonomous University of Barcelona and Interventional Cardiology Fellow of the Newcastle Upon Tyne Freeman Hospital (United Kingdom) for TAVI and complex PCI

Lessons from Tako-Tsubo
Thursday, October 27, 2022 – 17:15-17:25
Session: How to manage Chronic Coronary Syndromes (I) – ESC guidelines and beyond

Dan Dobreanu (Romania)

13 Dan Dobreanu

Professor in Physiology and Cardiology, University of Medicine and Pharmacy, Târgu Mureș

Pharmacological rhythm or rate control in patients with AF and HF?
Friday, October 28, 2022 10:05-10:15
Session: Drugs in heart failure (II)

Dobromir Dobrev (Germany)

14 Dobrev, Dobromir

Full Professor and Director of Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany
Adjunct Full Professor of Medicine at Montreal Heart Institute, University of Montreal, Canada and Baylor College of Medicine, Houston, USA

New antiarrhythmic drugs: new mechanisms
Saturday, October 29, 2022 – 11:10-11:20
Session: New drugs

Inka Miñambres Donaire (Spain)

15 Inka Miñambres Donaire

Senior Dr. Endocrinologist at Hospital de la Sant Creu i Sant Pau, Barcelona

Agents for prevention and treatment of overweight and obesity
Saturday, October 29, 2022 10:20-10:30
Session: How to choose for management of DM in patients with CV disease

Heinz Drexel (Austria)

Bregenz, 10.03.2016 Prim. Prof. Dr. Dr., Heinz Drechsel, Diabetes, Forschung, Labor, Pipette, VIVIT, Molekularbiologisches Labor, Campus

Professor of Medicine
Head of the Department of Internat Medicine & Intensive Care, County Hospital Bregenz – Bregenz
VIVIT-Research Institute, Academic Teaching Hospital Feldkirch

Chairperson
Friday, October 28, 2022 – 10:05-10:50
Session: Drugs in heart failure (II) – ESC guidelines and beyond 
Adherence and persistence
Friday, October 28, 2022 – 14:20-14:30
Session: Cardiovascular pharmacotherapy in the elderly (Joint WG-CVP)

Krzysztof J. Filipiak (Poland)

17 Krzysztof J. Filipiak

Professor and Rector Magnificus
Maria Sklodowska-Curie Medical Academy in Warsaw

Chairperson
Thursday, October 27, 2022 – 15:40-16:25
Session: Pharmacotherapy for hypertension in the world

Koji Hasegawa (Japan)

18 Koji Hasegawa

Clinical Professor, Faculty of Medicine at Kyoto University
Visiting Professor at University of Shizuoka
Director at Division of Translational Research in National Hospital Organization (NHO) Kyoto Medical Center and Leader of NHO Cardiovascular Clinical Research Network
Past president of International Society of Cardiovascular Pharmacotherapy

Anticoagulation therapy
Thursday, October 27, 2022 – 17:05-17:15
Session: How to manage Chronic Coronary Syndromes (I) – ESC guidelines and beyond 
Anticoagulation in HF
Friday, October 28, 2022 – 10:15-10:25
Session: Drugs in heart failure (II) – ESC guidelines and beyond 
Chairperson
Friday, October 28, 2022 – 16:05-17:00
Session: Controversial therapies
Chairperson
Saturday, October 29, 2022 – 10:00-10:40
Session: How to choose for management of DM in patients with CV disease

Azara Janmohamed (UK)

19 Azara Janmohamed

Doctor, consultant in Clinical Pharmacology and Therapeutics and General Internal medicine at St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK

Why is Pharmacogenomics important in Cardiovascular Pharmacotherapy?
Friday, October 28, 2022 12:45-13:15
Session: Pharmacogenomics [….] and Cardiovascular therapy

Ruxandra Jurcuț (Romania)

20 Ruxandra Jurcut

Head cardiologist at the Emergency Institute for Cardiovascular Diseases “Prof. Dr. C.C. Iliescu”. University Professor  at the University of Medicine and Pharmacy “Carol Davila”. Coordinator of the IUBCV Center for Expertise on Rare Genetic Cardiovascular Diseases, member of the European GUARD-Heart network dedicated to rare and complex heart diseases.

HOCMP: from alcohol to mavacamten
Saturday, October 29, 2022 – 09:00-09:10
Session: New trends in prevention pharmacotherapy – Joint European Association of Professors Emeriti (EAPE)

Thomas Kahan (Sweden)

21 Thomas Kahan

Professor of medicine at Karolinska Institutet, Stockholm, Sweden.
Head of cardiovascular research at Danderyd University Hospital
President of International Society of Cardiovascular Pharmacotherapy

Blood pressure control – Different strategies
Thursday, October 27, 2022 – 15:40-15:50
Session: Pharmacotherapy for hypertension in the world
Chairperson
Friday, October 28, 2022 – 11:20-12:05
Session: Drugs & cancer
Chairperson
Friday, October 28, 2022 – 17:10-17:35
Session: Presentation of the best 3 abstracts (5 min/each + 5 min discussion + Awards to them)
Chairperson
Friday, October 28, 2022 – 17:35-18:25
Session: Neufeld Lecture
Why to be a ISCP member and adjourn
Saturday, October 29, 2022 – 12:05-12:15
Session: Why to be a ISCP member and adjourn

Maki Komiyama (Japan)

22 Maki Komiyama

Chief Researcher, Clinical Research Institute,
National Hospital Organization Kyoto Medical Center

Chairperson
Friday, October 28, 2022 – 14:00-14:40
Session: Cardiovascular pharmacotherapy in the elderly (Join WG-CVP)

Daniel Lighezan (România)

23 Daniel Lighezan

Professor
Victor Babeş University of Medicine and Pharmacy, Timişoara
Primary Cardiology Physician; Primary Doctor Internal Medicine
Timişoara Municipal Emergency Clinical Hospital

Chairperson
Saturday, October 29, 2022 – 09:00-09:55
Session: New trends in prevention pharmacotherapy – Joint European Association of 
GLP1-RA pros/cons
Saturday, October 29, 2022 – 10:10-10:20
Session: How to choose for management of DM in patients with CV disease

Alberto Lorenzatti (Argentina)

24 Alberto Lorenzatti

Co-Director of the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care
(Head of the Clinical Research network)

Lipid profile and anti-lipidemic therapy (PCSK9, Inclisiran…)
Thursday, October 27, 2022 – 18:10-18:20
Session: How to manage Chronic Coronary Syndromes (II) – ESC guidelines and beyond
Chairperson
Saturday, October 29, 2022, 14:00 – 14:40
Session: Cardiovascular pharmacotherapy in the elderly (Join WG-CVP)
Chairperson
Friday, October 28, 2022 – 11:00-11:40
Session: New drugs

Emma Magavern (UK)

25 Emma Magavern

Dr. Magavern is a Clinical Pharmacology Registrar in London undertaking a PhD as a Clinical Research Fellow with Prof Mark Caulfield at the William Harvey Research Institute of QMUL

Pharmacogenomic aspects of Clopidogrel use in special populations
Friday, October 28, 2022 – 15:15-15:35
Session: Pharmacogenomics [….] and Cardiovascular therapy

Giuseppe Mancia (Italy)

Bayer Health Care Berlin 18.6.2008 Pressekonferenz 15.00 -16.00Uhr

Professor Emeritus at the University Milano-Bicocca
Milan, ITALY

How to treat HT in diabetics
Thursday, October 27, 2022 – 15:50-16:00
Session: Pharmacotherapy for hypertension in the world

Felipe Martinez (Argentina)

27 Felipe Martinez

Past Full Professor of Medicine. Cordoba National University (since 1994 till 2015)
Director. Instituto Damic and Fundacion Rusculleda. (since 1993)
Past president of International Society of Cardiovascular Pharmacotherapy

Chairperson
Thursday, October 27, 2022 – 16:35-17:40
Session: How to manage Chronic Coronary Syndromes (I) – ESC guidelines and beyond    
Chronic heart failure with reduced left ventricular function
Friday, October 28, 2022 – 09:10-09:20
Session: Drugs in heart failure (I) – ESC guidelines and beyond 
Chairperson
Friday, October 28, 2022 – 10:05-10:50
Session: Drugs in heart failure (II) – ESC guidelines and beyond 
How to prevent and treat heart failure in cancer patients
Friday, October 28, 2022 – 11:20-11:30
Session: Drugs & cancer
Chairperson
Friday, October 28, 2022 – 17:10-17:35
Session: Presentation of the best 3 abstracts (5 min/each + 5 min discussion + Awards to them)

Antoni Martinez-Rubio (Spain)

28 Antoni Martínez-Rubio

Director of the Dept. of Cardiology of the
Univ. Hospital of Sabadell (Univ. Autonoma of Barcelona)
Past president of International Society of Cardiovascular Pharmacotherapy

Pharmacological vs Interventional Treatment of AF in patients with HF
Friday, October 28, 2022 – 10:25-10:35
Session: Drugs in heart failure (II) – ESC guidelines and beyond 
How to prevent and treat thromboembolism in cancer patients
Friday, October 28, 2022 – 11:40-11:50
Session: Drugs & cancer
Chairperson
Friday, October 28, 2022 – 12:15-12:45
Session: The Best of the Year in Cardiovascular Therapy (ECR, the official journal of ISCP and EJCVP, ESC family journal)
Chairperson
Friday, October 28, 2022 – 17:35-18:25
Session: Neufeld Lecture
Chairperson
Saturday, October 29, 2022 – 10:00-10:40
Session: How to choose for management of DM in patients with CV disease

Georg Noll (Switzerland)

29 Georg Noll

Professor of Cardiology, University Hospital Zurich
Expert in General Cardiology, Internal Medicine, Hypertension, Heart Failure, Lipids, Education and Teaching.

Chairperson
Thursday, October 27, 2022 – 15:40-16:25
Session: Pharmacotherapy for hypertension in the world
What is optimal pharmacotherapy for angina pectoris?
Thursday, October 27, 2022 – 18:30-18:40
Session: How to manage Chronic Coronary Syndromes (II) – ESC guidelines and beyond 
Chairperson
Friday, October 28, 2022 – 09:00-09:55
Session: Drugs in heart failure (I) – ESC guidelines and beyond 
Chairperson
Friday, October 28, 2022 – 14:45-15:45
Session: Pharmacogenomics [….] and Cardiovascular therapy

Young Keun On (South Korea)

30 Young Keun ON

Professor of Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine

Chairperson
Friday, October 28, 2022 – 11:20-12:05
Session: Drugs & cancer

Peter Ong (Germany)

31 Peter Ong

Professor
Head of Clinical Research Unit, Department of Cardiology, Robert-Bosch Medical Centre, Stuttgart, Germany

Vasospastic angina
Thursday, October 27, 2022 – 18:00-18:10
Session: How to manage Chronic Coronary Syndromes (II) – ESC guidelines and beyond

Milton Packer (USA)

32 Milton Paker

Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center, Dallas, Texas

Neufeld Lecture
Friday, October 28, 2022 – 17:35-18:25
Session: Neufeld Lecture

Giovanni Palladini (Italy)

33 Giovanni Palladini

Professor of clinical chemistry at the University of Pavia and director of the Amyloidosis Research and Treatment Center at the Foundation “IRCCS Policlinico San Matteo”, Pavia, Italy

Better drugs for amyloidosis in 2022
Saturday, October 29, 2022 – 11:00-11:10
Session: New drugs

Alina Scridon (Romania)

34 Alina Scridon

Professor of Physiology, University of Medicine, Pharmacy, Science and Technology “George Emil Palade” of Târgu Mureș, Romania

Emerging therapies in acute heart failure: any light at the end of the tunnel?
Friday, October 28, 2022 – 09:00-09:10
Session: Drugs in heart failure (I) – ESC guidelines and beyond 

Anne Grete Semb (Norway)

35 Anne Grete Semb

Doctor, consultant cardiologist, senior researcher and the founder/leader of the Preventive Cardio-Rheuma clinic and the cardiovascular disease research group at Diakonhjemmet Hospital

Prevention and treatment of cardiovascular disease in patients with Immune Mediated Rheumatic diseases
Thursday, October 27, 2022 – 18:40-18:50
Session: How to manage Chronic Coronary Syndromes (II) – ESC guidelines and beyond

Juan Tamargo (Spain)

36 Juan Tamargo

Emeritus Professor of Pharmacology, School of Medicine, University Complutense of Madrid (UCM)

Role of anti-inflammatory treatment
Thursday, October 27, 2022 – 18:20-18:30
Session: How to manage Chronic Coronary Syndromes (II) – ESC guidelines and beyond 
Chairperson
Friday, October 28, 2022 – 09:00-09:55
Session: Drugs in heart failure (I) – ESC guidelines and beyond 
Chairperson
Friday, October 28, 2022 – 14:45-15:45
Session: Pharmacogenomics [….] and Cardiovascular therapy
Colchicine in CVD 2022: where and when
Friday, October 28, 2022 – 16:35-16:45
Session: Controversial therapies

Doreen Tan (Singapore)

37  Doreen Tan

Associate Professor, Clinical & Pharmacy Practice, at the National University of Singapore.

Chairperson
Thursday, October 27, 2022 – 18:00-19:05
Session: How to manage Chronic Coronary Syndromes (II) – ESC guidelines and beyond 
Anti-platelet therapy after PCI
Thursday, October 27, 2022 – 16:55-17:05
Session: How to manage Chronic Coronary Syndromes (I) – ESC guidelines and beyond 
Dosing challenges in women
Friday, October 28, 2022 – 16:45-16:55
Session: Controversial therapies

Jack Tan (Singapore)

38 Jack Tan

Adjunct associate professor appointments at Duke NUS and lecturer appointment at the Yong Loo Lin Medical School
Head of cardiology at the National Heart Centre Singapore and Sengkang General Hospital
Past president of International Society of Cardiovascular Pharmacotherapy

APSC consensus statements in HF
Friday, October 28, 2022 – 09:30-09:40
Session: Drugs in heart failure (I) – ESC guidelines and beyond

Viviany R. Taqueti (USA)

39 Viviany R Taqueti

Assistant Professor
Brigham and Women’s Hospital, Department of Radiology
Instructor, Harvard Medical School Cardiovascular Medicine, Radiology


Microvascular angina
Thursday, October 27, 2022 – 16:35-16:45
Session: How to manage Chronic Coronary Syndromes (I) – ESC guidelines and beyond

Filippos Triposkiadis (Greece)

40 Filippos Triposkiadis

Professor of Cardiology, Director of the Department of Cardiovascular Sciences, Director of the Postgraduate School in Cardiology and Coordinator of the PhD program in Cellular and Molecular Cardiology at the Catholic University in Rome


HFrEF versus HFpEF: the end of a myth
Saturday, October 29, 2022 – 09:15-09:30
Session: New trends in prevention pharmacotherapy – Joint European Association of Professors Emeriti (EAPE)

USEFUL LINKS

Login
Sign up
Password reset
Participant’s guide

LEGAL

Terms and conditions
Privacy policy
Delivery / return policy
ANPC

CONTACT

Media Med Publicis
10 Petofi Sandor street
Bucharest
+40 31 101 32 21
[email protected]